| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 12 | 2023 | 738 | 2.150 |
Why?
|
| Precursor Cells, B-Lymphoid | 6 | 2023 | 27 | 1.950 |
Why?
|
| Cell Differentiation | 11 | 2023 | 1521 | 1.200 |
Why?
|
| Receptors, Antigen, B-Cell | 5 | 2022 | 114 | 1.130 |
Why?
|
| Lymphopoiesis | 5 | 2019 | 48 | 0.960 |
Why?
|
| Immunoglobulins | 2 | 2015 | 144 | 0.870 |
Why?
|
| Chromatin | 4 | 2023 | 397 | 0.860 |
Why?
|
| Epigenesis, Genetic | 4 | 2024 | 506 | 0.840 |
Why?
|
| Recombination, Genetic | 4 | 2022 | 444 | 0.700 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2019 | 96 | 0.670 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 45 | 0.670 |
Why?
|
| Agammaglobulinemia | 1 | 2018 | 20 | 0.640 |
Why?
|
| Signal Transduction | 13 | 2023 | 3373 | 0.640 |
Why?
|
| STAT5 Transcription Factor | 4 | 2019 | 43 | 0.560 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 42 | 0.510 |
Why?
|
| Carrier Proteins | 1 | 2018 | 681 | 0.490 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2008 | 394 | 0.480 |
Why?
|
| Mice | 23 | 2024 | 11737 | 0.470 |
Why?
|
| Cell Cycle | 4 | 2012 | 509 | 0.460 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 726 | 0.460 |
Why?
|
| Mice, Knockout | 12 | 2020 | 1990 | 0.450 |
Why?
|
| Animals | 32 | 2024 | 27317 | 0.450 |
Why?
|
| Germinal Center | 3 | 2023 | 55 | 0.450 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2020 | 89 | 0.380 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 161 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 3209 | 0.360 |
Why?
|
| T-Lymphocytes | 5 | 2017 | 1223 | 0.350 |
Why?
|
| Receptors, Interleukin-7 | 4 | 2019 | 28 | 0.340 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 66 | 0.340 |
Why?
|
| Gene Expression Regulation | 6 | 2023 | 1975 | 0.330 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2008 | 13 | 0.330 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2008 | 16 | 0.330 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 198 | 0.320 |
Why?
|
| ras Proteins | 1 | 2009 | 130 | 0.320 |
Why?
|
| Pre-B Cell Receptors | 2 | 2019 | 8 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 2 | 2024 | 1087 | 0.280 |
Why?
|
| Interleukin-7 | 3 | 2020 | 41 | 0.270 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2018 | 109 | 0.260 |
Why?
|
| Genes, bcl-2 | 1 | 2005 | 16 | 0.250 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 665 | 0.250 |
Why?
|
| Cyclin D3 | 4 | 2013 | 21 | 0.240 |
Why?
|
| Cell Proliferation | 5 | 2023 | 1650 | 0.240 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 2 | 2017 | 37 | 0.240 |
Why?
|
| Thymus Gland | 4 | 2009 | 197 | 0.240 |
Why?
|
| Lymphocytes | 2 | 2017 | 471 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2018 | 126 | 0.240 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2003 | 18 | 0.230 |
Why?
|
| Membrane Proteins | 2 | 2008 | 1215 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 196 | 0.230 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 85 | 0.220 |
Why?
|
| Skin Transplantation | 1 | 2024 | 183 | 0.210 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 1429 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2009 | 100 | 0.210 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 354 | 0.210 |
Why?
|
| Pulmonary Artery | 1 | 2003 | 319 | 0.200 |
Why?
|
| Down-Regulation | 2 | 2015 | 519 | 0.190 |
Why?
|
| Antigens, CD1 | 2 | 1998 | 37 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 401 | 0.190 |
Why?
|
| Cellular Microenvironment | 1 | 2020 | 29 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 594 | 0.180 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 38 | 0.170 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2019 | 40 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2018 | 280 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2880 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2011 | 170 | 0.170 |
Why?
|
| Cell Survival | 5 | 2009 | 982 | 0.170 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 69 | 0.160 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 76 | 0.160 |
Why?
|
| Cell Nucleus | 2 | 2012 | 599 | 0.160 |
Why?
|
| CD79 Antigens | 1 | 2017 | 17 | 0.150 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2017 | 15 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 14 | 0.150 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2017 | 16 | 0.150 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 57 | 0.150 |
Why?
|
| Ubiquitination | 1 | 2017 | 71 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 207 | 0.150 |
Why?
|
| Receptors, Antigen | 1 | 2017 | 11 | 0.150 |
Why?
|
| Adenosine | 1 | 2020 | 237 | 0.150 |
Why?
|
| Endosomes | 1 | 2017 | 79 | 0.150 |
Why?
|
| Natural Killer T-Cells | 1 | 2017 | 45 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 232 | 0.140 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 135 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 557 | 0.140 |
Why?
|
| Up-Regulation | 2 | 2015 | 727 | 0.140 |
Why?
|
| Methylation | 2 | 2020 | 268 | 0.130 |
Why?
|
| RNA | 1 | 2020 | 578 | 0.130 |
Why?
|
| Base Sequence | 3 | 2020 | 2327 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 308 | 0.130 |
Why?
|
| Flow Cytometry | 3 | 2012 | 691 | 0.130 |
Why?
|
| Trans-Activators | 2 | 2010 | 443 | 0.130 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1995 | 2 | 0.130 |
Why?
|
| Protein Binding | 3 | 2020 | 1487 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2015 | 80 | 0.120 |
Why?
|
| Pregnancy Proteins | 1 | 1995 | 38 | 0.120 |
Why?
|
| Apoptosis | 2 | 2015 | 1716 | 0.120 |
Why?
|
| DNA Damage | 2 | 2023 | 371 | 0.120 |
Why?
|
| COS Cells | 2 | 2011 | 167 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2006 | 299 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1157 | 0.110 |
Why?
|
| Fetus | 1 | 1995 | 232 | 0.110 |
Why?
|
| Placenta | 1 | 1995 | 179 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2012 | 273 | 0.110 |
Why?
|
| Binding Sites | 2 | 2015 | 1117 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2006 | 465 | 0.100 |
Why?
|
| Binding, Competitive | 1 | 2011 | 146 | 0.100 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 171 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 556 | 0.100 |
Why?
|
| Male | 5 | 2024 | 42251 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2011 | 371 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2010 | 25 | 0.090 |
Why?
|
| Ammonium Sulfate | 2 | 2003 | 3 | 0.090 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2003 | 34 | 0.090 |
Why?
|
| Chromatography, Gel | 2 | 2003 | 103 | 0.090 |
Why?
|
| Cell Line | 4 | 2015 | 2495 | 0.090 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2009 | 23 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3027 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 73 | 0.090 |
Why?
|
| Humans | 10 | 2023 | 89063 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 42 | 0.090 |
Why?
|
| Cyclins | 1 | 2009 | 83 | 0.080 |
Why?
|
| Histones | 1 | 2011 | 329 | 0.080 |
Why?
|
| Receptor, Notch1 | 2 | 2006 | 94 | 0.080 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2008 | 21 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 123 | 0.080 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2008 | 20 | 0.080 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2008 | 22 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 78 | 0.080 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2006 | 16 | 0.080 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 277 | 0.080 |
Why?
|
| Cell Death | 1 | 2008 | 262 | 0.070 |
Why?
|
| beta Catenin | 1 | 2009 | 266 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 887 | 0.070 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2020 | 132 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 695 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 340 | 0.070 |
Why?
|
| Leukemia, T-Cell | 1 | 2006 | 17 | 0.070 |
Why?
|
| Child | 1 | 2018 | 7149 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 2062 | 0.070 |
Why?
|
| Lymphocyte Activation | 3 | 2019 | 751 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 412 | 0.070 |
Why?
|
| Adolescent | 1 | 2018 | 9237 | 0.060 |
Why?
|
| Type C Phospholipases | 1 | 2005 | 28 | 0.060 |
Why?
|
| Bone Marrow | 2 | 2019 | 445 | 0.060 |
Why?
|
| Caspase Inhibitors | 1 | 2005 | 33 | 0.060 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 39 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 162 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 607 | 0.060 |
Why?
|
| Chromatography | 1 | 2003 | 28 | 0.060 |
Why?
|
| Concanavalin A | 1 | 2003 | 52 | 0.060 |
Why?
|
| Fibrinolysin | 1 | 2003 | 26 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2005 | 268 | 0.060 |
Why?
|
| Liver | 2 | 2019 | 1205 | 0.060 |
Why?
|
| Trypsin | 1 | 2003 | 95 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2003 | 81 | 0.060 |
Why?
|
| Collagenases | 1 | 2003 | 41 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 269 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2003 | 85 | 0.060 |
Why?
|
| Cytosol | 1 | 2003 | 193 | 0.060 |
Why?
|
| Cellulose | 1 | 2003 | 55 | 0.060 |
Why?
|
| Cattle | 1 | 2003 | 375 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2022 | 1652 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2024 | 162 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 140 | 0.050 |
Why?
|
| Heparin | 1 | 2003 | 185 | 0.050 |
Why?
|
| Plasma Cells | 1 | 2023 | 84 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 432 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 638 | 0.050 |
Why?
|
| Transplantation Tolerance | 1 | 2024 | 134 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2003 | 794 | 0.050 |
Why?
|
| Female | 3 | 2024 | 46011 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 740 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 1241 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 235 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2003 | 755 | 0.050 |
Why?
|
| Cell Size | 1 | 2020 | 68 | 0.050 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 2019 | 4 | 0.040 |
Why?
|
| N-Formylmethionine | 1 | 1999 | 5 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 34 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 323 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 291 | 0.040 |
Why?
|
| Proteome | 1 | 2020 | 132 | 0.040 |
Why?
|
| Adult | 1 | 2018 | 26507 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2020 | 192 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 1998 | 155 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 69 | 0.040 |
Why?
|
| Proteomics | 1 | 2020 | 230 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 200 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2024 | 1064 | 0.040 |
Why?
|
| Oligopeptides | 1 | 1999 | 188 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1998 | 130 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 388 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 258 | 0.040 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2017 | 15 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 1998 | 293 | 0.040 |
Why?
|
| Epitopes | 1 | 1998 | 255 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 1130 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 66 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 646 | 0.040 |
Why?
|
| Spleen | 1 | 1998 | 432 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2017 | 96 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 1998 | 262 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2017 | 164 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 92 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 77 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2017 | 109 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 3009 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 153 | 0.040 |
Why?
|
| Endocytosis | 1 | 2017 | 180 | 0.030 |
Why?
|
| Computational Biology | 1 | 2020 | 542 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1997 | 130 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 112 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2017 | 291 | 0.030 |
Why?
|
| Antigens | 1 | 1997 | 229 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 167 | 0.030 |
Why?
|
| V(D)J Recombination | 1 | 2015 | 10 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 275 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 55 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1999 | 1400 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1995 | 4 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 628 | 0.030 |
Why?
|
| Chemical Precipitation | 1 | 1995 | 18 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1995 | 23 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1997 | 275 | 0.030 |
Why?
|
| Macrophages | 1 | 1998 | 571 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1995 | 331 | 0.030 |
Why?
|
| Time Factors | 1 | 2003 | 5320 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 266 | 0.030 |
Why?
|
| Genomics | 1 | 2020 | 761 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2011 | 0.030 |
Why?
|
| Cytokines | 1 | 1998 | 802 | 0.030 |
Why?
|
| Cyclin D2 | 1 | 2013 | 19 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 429 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1755 | 0.030 |
Why?
|
| Cell Division | 1 | 1995 | 696 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 172 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 267 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 30 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2012 | 96 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 1995 | 337 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 24 | 0.030 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 33 | 0.030 |
Why?
|
| DNA Primers | 1 | 2012 | 543 | 0.020 |
Why?
|
| Proteins | 1 | 1997 | 786 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2010 | 67 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2009 | 80 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 866 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2006 | 12 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2006 | 15 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2006 | 82 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 956 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2006 | 83 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2006 | 56 | 0.020 |
Why?
|
| Bortezomib | 1 | 2006 | 82 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2006 | 6 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2006 | 10 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2006 | 17 | 0.020 |
Why?
|
| Pyrazines | 1 | 2006 | 94 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2006 | 78 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 309 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2006 | 100 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 392 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 128 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 921 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 447 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 1533 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1574 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 2552 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 35 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1999 | 57 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 142 | 0.010 |
Why?
|
| Cricetinae | 1 | 1999 | 558 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 401 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 1999 | 215 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 1997 | 2 | 0.010 |
Why?
|
| Hemocyanins | 1 | 1997 | 7 | 0.010 |
Why?
|
| Antigens, Ly | 1 | 1997 | 37 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1997 | 103 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 1997 | 86 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1997 | 145 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 1528 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 668 | 0.010 |
Why?
|
| Th2 Cells | 1 | 1997 | 147 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 4132 | 0.010 |
Why?
|